Abstract

Epstein-Barr Virus/(EBV) is emerging as one of the most important co-factors in AIDS/ARC. Reactivation of EBV is common in AIDS and AIDS patients frequently develop EBV- associated lymphomas. In addition, it has recently been shown that HIV can replicate in B-cells transformed by EBV, but not in EBV-negative B-cells. In this proposal the molecular interactions between EBV and HIV will be studied. Using the EBV-negative Burkitt Lymphoma lines Ramos and BJAB and several EBV converted counterparts of these cell lines, the replication of HIV and the expression of transfected HIV genes will be analysed. Cell lines expressing individual latent EBV proteins (EBNA1, EBNA2, EBNA3, LMP) will be created and analysed for their ability to support HIV replication. Binding and fusion experiments will be performed to determine if the receptor used for the uptake of HIV into B-cells is T4 or some other entity. The effect of HIV-infection on EBV-expression in latently infected cells will also be analyzed. In addition lymphoma cells from AIDS-patients will be characterized to determine how many of these lymphomas that are EBV-positive. The EBV-positive lymphomas will be analyzed for association with specific substrains of EBV and for restricted expression of the latent EBV- genes.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025304-02
Application #
3138734
Study Section
(SRC)
Project Start
1987-09-01
Project End
1992-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost

  Institution

Name
State University of New York at Buffalo
Department
Type
School of Medicine & Dentistry
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260